Discover all the factors affecting Inhibikase Therapeutics's share price. IKT is currently rated as a Sucker Stock | Stockopedia. IKT - Inhibikase Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM). What are your Inhibikase Therapeutics, Inc. (IKT) stock predictions? 2 Wall Street analysts have issued ratings. Currently, 2 analysts rated IKT as Bullish, 0. How to buy IKT stock on Public · Sign up for a brokerage account on Public · Add funds to your Public account · Choose how much you'd like to invest in IKT. IKT - Inhibikase Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
Discover all the factors affecting Inhibikase Therapeutics's share price. IKT is currently rated as a Sucker Stock | Stockopedia. What is the current stock price of Inhibikase Therapeutics (IKT)?. The current stock price of Inhibikase Therapeutics (IKT) is $ as of September 11, 56 minutes ago. Inhibikase Therapeutics Inc (IKT) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. The Inhibikase Therapeutics Inc stock price today is What Is the Stock Symbol for Inhibikase Therapeutics Inc? The stock symbol for Inhibikase. Get the latest Inhibikase Therapeutics Inc (IKT) real-time quote, historical performance, charts, and other financial information to help you make more. Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Diseases and related disorders inside and. Inhibikase Therapeutics stock was originally listed at a price of $ in Dec 23, If you had invested in Inhibikase Therapeutics stock at $, your. Real-Time News, Market Data and Stock Quote for Inhibikase Therapeutics. View Inhibikase Therapeutics, Inc. IKT stock quote prices, financial information, real-time forecasts, and company news from CNN. Get Inhibikase Therapeutics Inc (IKT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Inhibikase Therapeutics Stock (NASDAQ: IKT) stock price, news, charts, stock research, profile. IKT | Complete Inhibikase Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. (IKT) share was $ The week high for Inhibikase Therapeutics, Inc. Stock is $ and the week low is $ View the real-time IKT price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. In the current month, IKT has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IKT average Analyst price target in the past 3 months is $ Get the latest Inhibikase Therapeutics Inc. (IKT) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Discover real-time Inhibikase Therapeutics, Inc. Common Stock (IKT) stock prices, quotes, historical data, news, and Insights for informed trading and. Inhibikase Therapeutics (IKT). (Delayed Data from NSDQ). $ USD. 35, (%). Updated Sep 11, PM ET. Track Inhibikase Therapeutics Inc (IKT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and.
See the latest Inhibikase Therapeutics Inc Ordinary Shares stock price (IKT:XNAS), related news, valuation, dividends and more to help you make your. Inhibikase Therapeutics Inc IKT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/25/24 · 52 Week Low View a financial market summary for IKT including stock price quote, trading volume, volatility, options volume, statistics, and other important company. Stock analysis for Inhibikase Therapeutics Inc (IKT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Stock analysis for Inhibikase Therapeutics Inc (IKT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company.
How Much Is The Employer Payroll Tax | Back Pain Relief 4 Life